Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIOW) Return on Sales (2022 - 2025)

Historic Return on Sales for Cardio Diagnostics Holdings (CDIOW) over the last 4 years, with Q3 2025 value amounting to 600.54%.

  • Cardio Diagnostics Holdings' Return on Sales fell 3858600.0% to 600.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 415.16%, marking a year-over-year decrease of 1839100.0%. This contributed to the annual value of 240.28% for FY2024, which is 2506000.0% up from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Return on Sales stood at 600.54% for Q3 2025, which was down 3858600.0% from 225.18% recorded in Q2 2025.
  • Cardio Diagnostics Holdings' Return on Sales' 5-year high stood at 163.66% during Q2 2024, with a 5-year trough of 5687.95% in Q1 2023.
  • Over the past 4 years, Cardio Diagnostics Holdings' median Return on Sales value was 299.15% (recorded in 2023), while the average stood at 1209.93%.
  • Per our database at Business Quant, Cardio Diagnostics Holdings' Return on Sales soared by 54265400bps in 2024 and then tumbled by -14780300bps in 2025.
  • Over the past 4 years, Cardio Diagnostics Holdings' Return on Sales (Quarter) stood at 2503.22% in 2022, then surged by 90bps to 261.57% in 2023, then dropped by -29bps to 336.73% in 2024, then plummeted by -78bps to 600.54% in 2025.
  • Its last three reported values are 600.54% in Q3 2025, 225.18% for Q2 2025, and 1739.43% during Q1 2025.